Belimumab Reduces the Frequency of Flares in Patients with Refractory SLE: DATA from Clinical Practice Setting

被引：0
|
作者：
Doria, Andrea [1 ]
Iaccarino, Luca [1 ]
Bettio, Silvano [1 ]
Frassi, Micol [2 ,3 ]
Andreoli, Laura [2 ,3 ]
Reggia, Rossella [2 ,3 ]
Zen, Margherita [1 ]
Nalotto, Linda [1 ]
Gatto, Mariele [1 ]
Pea, Lara [2 ,3 ]
Punzi, Leonardo [1 ]
Tincani, Angela [2 ,3 ]
机构：
[1] Univ Padua, Padua, Italy
[2] Spedali Civil Brescia, I-25125 Brescia, Italy
[3] Univ Brescia, Brescia, Italy
来源：
ARTHRITIS & RHEUMATOLOGY | 2014年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
671
引用
收藏
页码：S292 / S293
页数：2
相关论文
共 50 条
  • [41] SLE Medication Usage and Organ Damage Among Adult SLE Patients with SLE Treated with Belimumab (BEL): Pooled Data from Three Open-Label Extension Studies over 11+Years
    Touma, Zahi
    Arriens, Cristina
    Henning, Christine
    Carroll, Angela
    Curtis, Paula
    Levy, Roger A.
    Stohl, William
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 4651 - 4654
  • [42] YYKetogenic food pyramid for patients with refractory epilepsy: From theory to clinical practice
    Prudencio, Mariana Baldini
    Lima, Patricia de Azevedo
    Pruper de Freitas, Maria Camila
    Cartolano, Flavia de Conti
    Murakami, Daniela Kawamoto
    Teixeira Damasceno, Nagila Raquel
    REVISTA DE NUTRICAO-BRAZILIAN JOURNAL OF NUTRITION, 2017, 30 (01): : 99 - 108
  • [43] EVALUATION OF SATISFACTION AND EFFICACY OF SWITCHING FROM INTRAVENOUS TO SUBCUTANEOUS BELIMUMAB IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS IN DAILY CLINICAL PRACTICE
    Frade-Sosa, B.
    Salman Monte, T. C.
    Narvaez, J.
    Peralta Garcia, I.
    Sandoval, S.
    Magallares, B.
    Heredia, S.
    Sapena, N.
    Riveros-Frutos, A.
    Olive, A.
    Corominas, H.
    Cortes-Hernandez, J.
    Gomez-Puerta, J. A.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1460 - 1461
  • [44] The Effect of Belimumab on Steroid Use in Patients with SLE: Results from a Retrospective Observational Study of Real-World Data from a US Rheumatology Provider Network
    Worley, Karen
    Milligan, Scott
    Rubin, Bernard
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 2949 - 2951
  • [45] Impact of up to 24 Months Intravenous (IV) Belimumab (BEL) Treatment on Steroid Use and Disease Activity in Patients with SLE in Clinical Practice: Additional Post Hoc Pooled Analysis of Multicountry OBSErve Cohort Data
    Moldaver, Daniel
    Anderson, Seth
    Bracher, Marguerite
    Levy, Roger A.
    Quasny, Holly A.
    Wood, Robert
    Wild, Rosie
    Cusmano, Alexandra
    Rottier, Elke
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 1159 - 1161
  • [46] Determinants of neuropsychiatric flares in patients with systemic lupus erythematosus: results from five phase III trials of belimumab
    Palazzo, Leonardo
    Lindblom, Julius
    Cetrez, Nursen
    Ala, Henri
    Parodis, Ioannis
    RHEUMATOLOGY, 2024, 63 (03) : 798 - 808
  • [47] Dosage and frequency of infliximab in clinical practice: Data from the STURE registry.
    van Vollenhoven, RF
    Klareskog, L
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S135 - S136
  • [48] Satisfaction and effectiveness of switching from intravenous to subcutaneous belimumab treatment in daily clinical practice
    Frade-Sosa, Beatriz
    Salman-Monte, Tarek Carlos
    Narvaez, Javier
    Peralta, Irene
    Sandoval, Sebastian
    Magallares, Berta
    Heredia, Sergi
    Sapena, Nuria
    Riveros-Frutos, Anne
    Olive, Alejandro
    Corominas, Hector
    Cortes-Hernandez, Josefina
    Gomez-Puerta, Jose A.
    LUPUS, 2024, 33 (05) : 481 - 489
  • [49] 24-Month Outcomes Associated with Belimumab in Black/African-American Patients with Systemic Lupus Erythematosus in a Clinical Practice Setting in the United States
    Collins, Christopher
    Kerr, Gail
    Von Feldt, Joan
    Rubin, Bernie
    Katz, Arie
    Castellano, Vanessa
    Chung, Jake
    Bell, Christopher
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [50] Baseline Predictors of Systemic Lupus Erythematosus Flares: Data From the Combined Placebo Groups in the Phase III Belimumab Trials
    Petri, Michelle A.
    van Vollenhoven, Ronald F.
    Buyon, Jill
    Levy, Roger A.
    Navarra, Sandra V.
    Cervera, Ricard
    Zhong, Z. John
    Freimuth, William W.
    ARTHRITIS AND RHEUMATISM, 2013, 65 (08): : 2143 - 2153
12345